BMT and Cellular Immunotherapy Team
The largest transplant practice of its kind in the southeastern United States, Moffitt Cancer Center’s Blood and Marrow Transplant and Cellular Immunotherapy (BMT CI) Program provides patients with comprehensive diagnostic, donor matching, transplant as well as chimeric antigen receptor or CAR T cell therapy, other immunotherapy, and supportive care services in a single location.
Our BMT and cellular immunotherapy specialists cater to patients with leukemia, multiple myeloma, lymphoma, aplastic anemia, myelodysplastic syndrome (MDS), myelofibrosis, sickle cell anemia and certain solid tumors such as germ cell tumor. Moffitt’s patients benefit from the expertise of physicians who focus exclusively on the treatment of hematological conditions with transplant and CAR T, and collaborate to develop individualized treatment plans. It is this level of attention – combined with our advanced treatments and compassionate care – that leads to better outcomes and improved quality of life for our patients.
A key distinguishing factor of Moffitt’s BMT CI program is the talented physicians who make up our team. Here, experienced medical oncologists, hematologists, pathologists, psychologists and other specialists such as social workers provide a full spectrum of treatment and supportive care to our patients.
BMT information for referring physicians
There are several reasons why physicians throughout the nation refer patients to Moffitt’s Blood and Marrow Transplant and Cellular Immunotherapy Program (BMT CI). For example, Moffitt is:
- A National Marrow Donor Program (NMDP) transplant and collection center
- Fully accredited by the Foundation for the Accreditation of Cellular Therapy (FACT)
- Among a select few providers to offer bone marrow transplantation (BMT) to adults ages 70 and older
- One of only a handful of centers in the nation performing a high volume of transplants with outcomes exceeding expected survival
- A core member of the BMT Clinical Trials Network (BMT CTN) that spearheads an ambitious clinical trials program through which our patients can receive the latest treatment breakthroughs
- A center performing transplants from various donor types including related haploidentical and mismatched unrelated donors
- A center specialized in the treatment of patients with severe and refractory graft-versus-host disease (GVHD)
- A center conducting a high volume of CAR T cell therapy for lymphoma, myeloma and leukemia under the dedicated Immune Cell Therapy (ICE-T) service, and has led many pivotal national clinical trials for CAR T cell therapy
- A center with a dedicated survivorship program for BMT and CAR T recipients
To refer a patient to Moffitt’s BMT and cellular immunotherapy specialists, complete our online form or contact a physician liaison. We place emphasis on minimizing referral times and aim to respond to all referrals on the same business day that they are received.
Medically reviewed by Taiga Nishihori, MD, Blood and Marrow Transplant and Cellular Immunotherapy Program
-
BMT and CI Leadership
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Title
Program Leader, Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Blood and Marrow Transplant and Cellular Immunotherapy
4.9 (26)
Department Chair, Blood and Marrow Transplant and Cellular ImmunotherapyProgram Lead, Blood and Marrow Transplant and Cellular ImmunotherapyProgram
Blood and Marrow Transplant and Cellular Immunotherapy
Title
Program Co-Leader, Immuno-Oncology; Chair, Department of Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Blood and Marrow Transplant and Cellular Immunotherapy
5 (8)
-
Blood and Marrow Transplant & Cellular Immunotherapy at Magnolia Campus
Meet the providers located in Tampa, FL.
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Blood and Marrow Transplant and Cellular Immunotherapy
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Blood and Marrow Transplant and Cellular Immunotherapy
Cancer Focus
Acute Myeloid Leukemia (AML), Graft-vs-Host Disease (GVHD), Leukemia, Myelodysplastic Syndromes (MDS)
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Blood and Marrow Transplant and Cellular Immunotherapy
Cancer Focus
Multiple Myeloma-Plasma Cell Disorders
5 (248)
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Blood and Marrow Transplant and Cellular Immunotherapy
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Title
Program Leader, Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Blood and Marrow Transplant and Cellular Immunotherapy
Cancer Focus
Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndromes (MDS)
4.9 (26)
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Medical Oncology
Cancer Focus
Multiple Myeloma-Plasma Cell Disorders
4.9 (48)
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Blood and Marrow Transplant and Cellular Immunotherapy
Cancer Focus
Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndromes (MDS)
5 (23)
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Medical Oncology
Cancer Focus
Multiple Myeloma-Plasma Cell Disorders
5 (57)
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Blood and Marrow Transplant and Cellular Immunotherapy
Cancer Focus
Hodgkin Lymphoma, Non-Hodgkin Lymphoma
4.9 (14)
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Blood and Marrow Transplant and Cellular Immunotherapy
Cancer Focus
Multiple Myeloma-Plasma Cell Disorders
5 (35)
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Blood and Marrow Transplant and Cellular Immunotherapy
Cancer Focus
Hodgkin Lymphoma, Non-Hodgkin Lymphoma
5 (42)
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Blood and Marrow Transplant and Cellular Immunotherapy
Cancer Focus
Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), Classical Hematology, Hodgkin Lymphoma, Leukemia, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma
4.8 (33)
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Blood and Marrow Transplant and Cellular Immunotherapy
Cancer Focus
Hodgkin Lymphoma, Non-Hodgkin Lymphoma
4.9 (29)
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Blood and Marrow Transplant and Cellular Immunotherapy
Cancer Focus
Cutaneous Lymphoma (CTCL), Hodgkin Lymphoma, Multiple Myeloma-Plasma Cell Disorders, Non-Hodgkin Lymphoma
4.9 (43)
Department Chair, Blood and Marrow Transplant and Cellular ImmunotherapyProgram Lead, Blood and Marrow Transplant and Cellular ImmunotherapyProgram
Blood and Marrow Transplant and Cellular Immunotherapy
Title
Program Co-Leader, Immuno-Oncology; Chair, Department of Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Blood and Marrow Transplant and Cellular Immunotherapy
Cancer Focus
Hodgkin Lymphoma, Multiple Myeloma-Plasma Cell Disorders, Non-Hodgkin Lymphoma
5 (8)
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Hematology/Oncology
Cancer Focus
Autoimmune Disorders, Hodgkin Lymphoma, Leukemia, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma
5 (20)
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Blood and Marrow Transplant and Cellular Immunotherapy
Cancer Focus
Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndromes (MDS)
5 (20)
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Blood and Marrow Transplant and Cellular Immunotherapy
Cancer Focus
Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Chronic Myeloid Leukemia (CML), Hodgkin Lymphoma, Leukemia, Multiple Myeloma-Plasma Cell Disorders, Myelodysplastic Syndromes (MDS), Neurofibromatosis, Non-Hodgkin Lymphoma, Testicular Cancer
4.9 (51)
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Blood and Marrow Transplant and Cellular Immunotherapy
Cancer Focus
Leukemia, Myelodysplastic Syndromes (MDS)
5 (42)
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Hematology
Cancer Focus
Graft-vs-Host Disease (GVHD), Leukemia, Multiple Myeloma-Plasma Cell Disorders, Myelodysplastic Syndromes (MDS)
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Blood and Marrow Transplant and Cellular Immunotherapy
Cancer Focus
Leukemia, Myelodysplastic Syndromes (MDS)
5 (38)
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Hematology/Oncology
Cancer Focus
Hodgkin Lymphoma, Leukemia, Multiple Myeloma-Plasma Cell Disorders, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Hematology/Oncology
Cancer Focus
Leukemia, Myelodysplastic Syndromes (MDS)
4.9 (29)
Program
Blood and Marrow Transplant and Cellular Immunotherapy
Specialty
Blood and Marrow Transplant and Cellular Immunotherapy
Cancer Focus
Leukemia, Myelodysplastic Syndromes (MDS)
4.8 (29)
